Riskpilot← Back to searchSign inGet full accessFEVACIL ApS
APSActiveCVR 30065964Søfrydsvej 10Business and other management consultancy activities · NACE 7020Est. 2006— employees
Revenue 2024
DKK 270K
+178% vs 2023
EBITDA margin
100.0%
+178% vs 2023
Equity ratio
95.9%
Financial strength
Net profit 2024
DKK 4,2M
+597% vs 2023
| Revenue | DKK 270K | +178% |
| EBITDA | DKK 270K | +178% |
| Net profit | DKK 4,2M | +597% |
| Total assets | DKK 8,5M | +87% |
| Equity | DKK 8,1M | +84% |
| Employees | — | — |
Legal name
FEVACIL ApS
CVR number
30065964
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
15. november 2006
Share capital
DKK 125.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør.
Company purpose
Selskabets formål er handel og investering.
Address
Søfrydsvej 10
Phone
+4528757675
Email
theander@cmp.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -11 | -12 | -13 | -12 | -13 | -11 | -11 | -11 | -11 | -32 | -11 | 97 | 270 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -11 | -12 | -13 | -12 | -13 | -11 | -11 | -11 | -11 | -32 | -11 | 97 | 270 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -11 | -12 | -13 | -12 | -13 | -11 | -11 | -11 | -11 | -32 | -11 | 97 | 270 |
| Net financials | 160 | 188 | 149 | 197 | -107 | 220 | -106 | -4 | 37 | 3.469 | -244 | 643 | 4.333 |
| Profit before tax | 149 | 176 | 136 | 185 | -120 | 208 | -117 | -15 | 26 | 3.437 | -255 | 740 | 4.603 |
| Tax | 20 | 46 | 34 | 44 | 9 | 21 | -0 | -0 | -0 | 93 | -0 | 136 | 394 |
| Net profit | 129 | 130 | 102 | 141 | -129 | 188 | -117 | -15 | 26 | 3.344 | -255 | 604 | 4.209 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 881 | 1.061 | 1.142 | 1.263 | 1.111 | 1.298 | 1.182 | 1.165 | 1.081 | 4.401 | 3.943 | 4.543 | 8.491 |
| Equity | 854 | 984 | 1.086 | 1.227 | 1.098 | 1.286 | 1.169 | 1.154 | 1.070 | 4.301 | 3.931 | 4.417 | 8.147 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 27 | 77 | 56 | 37 | 12 | 12 | 13 | 11 | 11 | 100 | 12 | 125 | 345 |
| Total debt | 27 | 77 | 56 | 37 | 12 | 12 | 13 | 11 | 11 | 100 | 12 | 125 | 345 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20122024
Equity ratio
95.9%
This company
38.2%
Market median
+151% vs market
20122024
Return on equity
51.7%
This company
18.4%
Market median
+181% vs market
20122024
Net profit margin
1556.6%
This company
8.1%
Market median
+19117% vs market
20122024
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20122024
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2006 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
FEVACIL ApS 
NextGen Vaccines Holding ApSBoard members of FEVACIL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|